Vimarsana
Biggest News Aggregation in the World

Page 45 - Cll News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cll Today - Breaking & Trending Today

Patients With CLL Could Also Face Autoimmune Complications, Expert Says - Vimarsana News

Patients With CLL Could Also Face Autoimmune Complications, Expert Says

Autoimmune diseases in patients with CLL are separate from CLL, which calls for different treatments.

Venetoclax Monotherapy Leads to Responses, Genomic Changes in R/R CLL - Vimarsana News

Venetoclax Monotherapy Leads to Responses, Genomic Changes in R/R CLL

Jennifer A. Woyach, MD, elucidates the updated results generated from a phase 2 study of venetoclax monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) whose disease progressed on a prior B-cell receptor inhibitor, expanded on key findings from a genomic analysis from the study, and highlighted what these findings could mean for the CLL treatment paradigm.

Chronic Lymphocytic Leukemia (CLL) | Oncology & Cancer News - Vimarsana News

Chronic Lymphocytic Leukemia (CLL) | Oncology & Cancer News

The Chronic Lymphocytic Leukemia (CLL) condition center is a comprehensive resource for cancer news & oncologist insights on CLL Read more about cancer at CURE.

After Cancer, I'm More Vigilant About Health Risks - Vimarsana News

After Cancer, I'm More Vigilant About Health Risks

After receiving two cancer diagnoses, I became more vigilant about my health — especially during the COVID-19 pandemic.

Calquence Had Fewer Heart Complications Than Imbruvica in CLL Treatment - Vimarsana News

Calquence Had Fewer Heart Complications Than Imbruvica in CLL Treatment

Fewer patients with chronic lymphocytic leukemia experienced cardiac toxicities with Calquence than those treated with Imbruvica, research showed.